Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tempo Bioscience
San Francisco, California, United Statestempobioscience.com ↗
- Ownership
- Private
- Employees
- ~10
- Development stage
- Commercial
01
Overview
Tempo Bioscience develops patient-relevant human iPSC-derived cell models—including organoids and spheroids—and live-cell biosensor assays to advance non-clinical drug discovery, safety evaluation, bioprocessing optimization, in vitro diagnostics, and biomarker development. Their platforms are widely adopted by pharma/biotech companies for early-stage R&D.
- Modalities
- Small moleculeBiologicGene therapyCAR-T cell therapysiRNA/mRNA therapiesCell therapyRecombinant protein
- Industry
- Non-Drug Biotech
02
Partnerships
Not specifically disclosed; serves pharma/biotech industry broadly with collaborations.
Beyond the preview
Go deeper on Tempo Bioscience.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tempo Bioscience.